S.22 (Act 61)
An act relating to health care practitioners administering stem cell products not approved by the U.S. Food and Drug Administration
Sponsors:
Sen. Virginia Lyons
,
Sen. Richard McCormack
Last Recorded Action: 5/21/2021 - Senate Message, signed by Governor June 7, 2021
Staff & Other Information
Regular Session 2021-2022
- Staff
- Jennifer Carbee